Lucid Diagnostics Income Statement (2022-2025) | LUCD

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.19M0.08M0.11M0.45M0.16M0.78M1.04M1.00M0.98M1.17M1.20M0.83M1.20M1.21M
Cost of Revenue 3.32M3.87M3.93M5.01M4.13M4.03M3.84M4.41M4.19M4.21M4.06M4.00M4.07M4.01M4.29M
Gross Profit -0.18M0.08M-4.90M-3.68M-3.87M-3.05M-3.37M-3.19M-3.23M-2.88M-2.81M-3.24M-2.81M-3.08M
Operating items
Amortization - Intangibles 0.64M0.51M0.51M0.51M0.51M0.51M0.51M0.37M0.10M0.10M0.11M0.10M0.10M0.10M
Research & Development 2.88M3.44M2.70M2.44M1.89M1.83M1.61M1.92M1.50M1.37M1.67M1.45M1.43M1.25M1.27M
Selling, General & Administrative 5.89M6.68M5.69M5.51M6.90M3.83M4.32M4.21M4.07M4.87M5.36M5.86M6.16M5.62M5.61M
Other Operating Expenses -12.46M4.51M6.06M7.14M5.97M6.09M5.98M6.37M6.22M5.93M5.84M6.25M5.72M5.67M6.09M
Operating Expenses 12.46M14.63M14.45M15.09M14.76M11.74M11.91M12.49M11.79M12.17M12.87M13.57M13.31M12.55M12.97M
Operating Income -12.27M-14.63M-14.38M-14.97M-14.32M-11.58M-11.13M-11.45M-10.79M-11.19M-11.69M-12.38M-12.49M-11.38M-11.76M
EBIT -12.27M-14.63M-14.38M-14.97M-14.32M-11.58M-11.13M-11.45M-10.79M-11.19M-11.69M-12.38M-12.49M-11.38M-11.76M
Non-operating items
Interest & Investment Income 0.00M0.00M0.03M0.06M0.08M0.14M0.12M0.09M0.07M0.11M0.08M0.07M0.07M0.11M0.10M
Other Non Operating Income 0.00M0.00M0.03M0.05M-1.93M0.20M-3.08M0.62M0.18M-0.51M-0.68M-4.05M-14.42M6.95M1.36M
Non Operating Income 0.00M0.00M0.03M0.05M-1.93M0.20M-3.08M0.62M0.18M0.19M-0.68M0.83M-14.42M6.95M1.36M
Net income details
EBT -12.27M-14.62M-14.35M-14.93M-16.25M-11.38M-14.21M-10.83M-10.61M-11.01M-12.37M-11.54M-26.91M-4.44M-10.40M
Profit After Tax -12.27M-14.62M-14.35M-14.93M-16.25M-11.38M-14.21M-10.83M-10.61M-11.01M-12.37M-11.54M-26.91M-4.44M-10.40M
Income from Continuing Operations -12.27M-14.62M-14.35M-14.93M-16.25M-11.38M-14.21M-10.83M-10.61M-11.01M-12.37M-11.54M-26.91M-4.44M-10.40M
Consolidated Net Income -12.27M-14.62M-14.35M-14.93M-16.25M-11.38M-14.21M-10.83M-10.61M-11.01M-12.37M-11.54M-26.91M-4.44M-10.40M
Income towards Parent Company -12.27M-14.62M-14.35M-14.93M-16.25M-11.38M-14.21M-10.83M-10.61M-11.01M-12.37M-11.54M-26.91M-4.44M-10.40M
Preferred Dividend Payments 7.50M9.11M3.45M
Net Income towards Common Stockholders -12.27M-14.62M-14.35M-14.93M-16.25M-11.38M-14.21M-10.83M-18.11M-11.01M-12.37M-11.54M-36.02M-7.89M-10.40M
Additional items
EPS (Basic) -0.35-0.41-0.39-0.40-0.40-0.27-0.34-0.25-0.40-0.23-0.25-0.23-0.52-0.08-0.10
EPS (Weighted Average and Diluted) -0.41-0.39-0.40-0.40-0.27-0.34-0.25-0.40-0.23-0.25-0.23-0.52-0.08-0.10
Shares Outstanding (Weighted Average) 35.12M35.76M36.41M36.17M40.97M41.83M41.86M41.76M45.01M48.21M50.37M50.52M68.80M98.99M108.18M
Shares Outstanding (Diluted Average) 35.76M36.41M36.17M40.97M41.83M41.86M41.76M45.01M48.21M50.37M50.52M68.80M98.99M108.18M
EBITDA -12.27M-14.63M-14.38M-14.97M-14.32M-11.58M-11.13M-11.45M-10.79M-11.19M-11.69M-12.38M-12.49M-11.38M-11.76M
Interest Expenses 0.03M0.22M0.15M0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.00M